Visible Alpha on S&P Capital IQ Pro
Unlock new consensus insights—powering everything from company forecasts to drug-level intelligence in one unified platform
Transform Your Approach to Company Research
Discover a comprehensive resource offering forecasts, assumptions, and insights from fully operational sell-side models.
This unique dataset provides an in-depth consensus view of companies and industries, enabling you to understand the factors driving future performance through detailed product, segment, and industry forecasts.
See How Analysts Model Companies
Access over 200 million data points and over 1 million unique consensus estimates. These insights are sourced from the analyst models of more than 200 brokers, featuring contributors that you won't find anywhere else.
Unlock the Benefit of an all-in-one Financial Market Intelligence Platform
In one unified platform, buy-side, sell-side, and corporate professionals gain access to:
- Comprehensive financial data,
- Standardized estimates, and
- Advanced analytical tools.
This integrated experience also serves as the foundation for advanced add-ons like Visible Alpha BioPharma, enabling a seamless transition from company-level analysis to asset-level insights.
Uncover Drug-Level Intelligence with BioPharma
Visible Alpha BioPharma, available as an add-on to Visible Alpha Estimates on S&P Capital IQ Pro, brings consensus insights down to the asset level—connecting company performance directly to individual drug outcomes.
- Analyze Drug-Level Forecasts with revenue estimates by indication and geography to identify key growth drivers.
- Assess Risk and Market Expectations with probability of success, patent timelines, and see where sell-side model assumptions diverge.
- Understand Competitive Positioning by screening across therapeutic areas, clinical phases, and MOAs to map the competitive landscape.
Dataset Benefits
Wide Coverage
Access consensus estimates for 7,300+ companies across more than 170 different industries.
Granular Data
Leverage over 200 million data points, including 1 million+ consensus line items, with an average of 156 consensus line items per company.
Proprietary Historicals
Discover hidden trends and drivers with VA Actuals, enhancing historical data from filings and crowdsourced estimates, featuring built-in standardization for easy company comparisons.
High Source Count
We work with over 250 sell-side firms, who contribute their full working models.
Consistently Up to Date
Trust in the freshness of our data; revisions and other updates to analyst models are reflected in our consensus within 24 hours, on average.
Explore Flexible Delivery Options for a Competitive Edge in Global Markets
Receive data via the S&P Capital IQ Pro platform, Capital IQ Pro Office, or the Visible Alpha Insights platform, providing on-demand enterprise access.
Directly access and query Visible Alpha data via Snowflake, a cloud-based offering, to eliminate the data ingestion process and improve productivity and efficiency.
Request Follow Up
Let us show you how institutional investors are leveraging our innovative, integrated platform to optimize their workflow through instant access to full working sell-side models and granular consensus estimates.